AlphaYouJB
Congress trade
Sen. John Boozman (R-AR) bought $1K-$15K of Dexcom Inc (DXCM) stock
John Boozman, U.S. Senator (R-AR), disclosed a purchase of Dexcom Inc (DXCM) stock worth $1K-$15K in a STOCK Act filing on Feb 15, 2026.
The trade happened on Jan 26, 2026, 20 days before it was made public.
DXCM has moved +21.6% since the trade date, from $73.34 to $89.17 (Sep 21, 2026 close).
- Traded
- Jan 26, 2026
- Disclosed
- Feb 15, 2026
- Filing delay
- 20 days
- Price since
- +21.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (22)
More DXCM insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.